Premium
This is an archive article published on August 4, 2005

RIL eyes biotech, healthcare, M&As

There may have been no big-ticket acquisition or foray into virgin territory, but Mukesh Ambani unveiled massive investment and growth strat...

.

There may have been no big-ticket acquisition or foray into virgin territory, but Mukesh Ambani unveiled massive investment and growth strategies for his core businesses, including refinery, petrochemicials, oil exploration, production and marketing.

The elder Ambani said his future plans included entering life sciences, particularly bio-technology and healthcare space. Mukesh said RIL would invest Rs 25,000 crore to double refining capacity in Jamnagar to 60 million tonnes from the current 30 million tonnes, making it the world’s largest single-location refinery by 2008-09.

RIL, he said, would invest another Rs 17,600 crore in 4-5 years for upstream oil and gas exploration and production. RIL will spend another Rs 3,000 crore for enhancing the polyester capacity to 2 mtpa and Rs 1,100 crore for hiking polypropelene capacity to 1.43 mtpa by March 2006.

Story continues below this ad

‘‘RIL will continue to evaluate opportunities for acquisition in petrochem domain,’’ Ambani said. ‘‘Increase in scale, overseas forays and acquisitions and exports will enable RIL to become a global petrochem major,’’ he said.

On exploration, Ambani said RIL won five exploration blocks under the fifth round of NELP. RIL has made 10 more oil and gas discoveries in the last 12 months taking the total discoveries to 23, each named after his father Dhirubhai. ‘‘We want to increase to 100 Dhirubhai discoveries,’’ he said.

With global scale refinery facility and gas findings, he said RIL intends to become a ‘‘global energy major’’ while helping India secure its energy needs.

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement